Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 7/20 | 0.51 |
| ▸ | RAB9A | P51151 | 7/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | IGF2BP2 | Q9Y6M1 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | PDE6D | O43924 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 4/20 | 0.35 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29566424 | 1.00 | NPC1 (0.51) | NPC1RAB9ALMNAIGF2BP2ALDH1A1 | |
| SCHEMBL7921927 | 0.94 | NPC1 (0.46) | NPC1RAB9ALMNAIGF2BP2ALDH1A1 | |
| SCHEMBL7160226 | 0.90 | NPC1 (0.49) | NPC1RAB9ALMNAIGF2BP2ALDH1A1 | |
| SCHEMBL16581362 | 0.89 | NPC1 (0.41) | NPC1RAB9ALMNAIGF2BP2ALDH1A1 | |
| SCHEMBL29384531 | 0.89 | NPC1 (0.41) | NPC1RAB9ALMNAIGF2BP2ALDH1A1 | |
| SCHEMBL29315721 | 0.87 | NPC1 (0.42) | NPC1RAB9ALMNAIGF2BP2ALDH1A1 | |
| SCHEMBL29315723 | 0.85 | NPC1 (0.41) | NPC1RAB9ALMNAIGF2BP2ALDH1A1 | |
| SCHEMBL29315727 | 0.84 | NPC1 (0.40) | NPC1RAB9ALMNAIGF2BP2ALDH1A1 | |
| SCHEMBL29315728 | 0.84 | NPC1 (0.40) | NPC1RAB9ALMNAIGF2BP2ALDH1A1 | |
| SCHEMBL4189444 | 0.84 | THRB (0.53) | NPC1RAB9ALMNAIGF2BP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1020 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595368-B2 | UV/HEVL-filtering contact lenses | ALCON INC. (CH) | 2026-04-07 | — | — | US | claimed |
| US-20250223392-A1 | HYDROPHILIZED POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS AND USES THEREOF | ALCON INC (CH) | 2025-07-10 | — | — | US | claimed |
| US-12286501-B2 | Hydrophilized polydiorganosiloxane vinylic crosslinkers and uses thereof | ALCON INC. (CH) | 2025-04-29 | — | — | US | claimed |
| US-20250052927-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2025-02-13 | — | — | US | claimed |
| US-20240392055-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2024-11-28 | — | — | US | claimed |
| US-20240383865-A1 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | ALCON INC (CH) | 2024-11-21 | — | — | US | claimed |
| US-20240254269-A1 | HYDROPHILIZED POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS AND USES THEREOF | ALCON INC. (CH) | 2024-08-01 | — | — | US | claimed |
| US-11926689-B2 | Hydrophilized polydiorganosiloxane vinylic crosslinkers and uses thereof | ALCON INC. (CH) | 2024-03-12 | — | — | US | claimed |
| WO-2023228055-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-30 | — | — | WO | claimed |
| US-20230374306-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-23 | — | — | US | claimed |
| US-20100296049-A1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | ALCON INC. (CH) | 2010-11-25 | — | — | US | claimed |
| WO-2010133680-A1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | NOVARTIS AG (CH) | 2010-11-25 | — | — | WO | claimed |
| WO-2006113164-A1 | UV-ABSORBING LAYER FOR POLARIZER PLATE | NITTO DENKO CORPORATION (JP) | 2006-10-26 | — | — | WO | claimed |
| US-20060234035-A1 | Protective cover sheet comprising a UV-absorbing layer for a polarizer plate and method of making the same | EASTMAN KODAK COMPANY | 2006-10-19 | — | — | US | claimed |
| EP-1153076-A4 | POLYMER LATEX FOR UV ABSORPTION ON DIFFERENT SUBSTRATES | MILLIKEN RES CORP (US) | 2004-12-15 | — | — | EP | claimed |
| US-6482757-B2 | FABRIC SUBSTRATE | MILLIKEN & COMPANY | 2002-11-19 | — | — | US | claimed |
| EP-1153076-A1 | POLYMER LATEX FOR UV ABSORPTION ON DIFFERENT SUBSTRATES | MILLIKEN RESEARCH CORPORATION (US) | 2001-11-14 | — | — | EP | claimed |
| US-20010012743-A1 | Polymer latex for ultraviolet absorption on different substrates | VOGT KIRKLAND W (US) | 2001-08-09 | — | — | US | claimed |
| US-6194330-B1 | EMULSION POLYMERIZATION OF A BENZOTRIAZOLE- OR BENZOPHENONE-CONTAINING MONOMER WITH A VINYL FUNCTIONAL MONOMER IN THE PRESENCE OF A CHAIN TRANSFER AGENT, PREFERABLY 1-DODECANETHIOL | MILLIKEN & COMPANY | 2001-02-27 | — | — | US | claimed |
| WO-2000006643-A1 | POLYMER LATEX FOR UV ABSORPTION ON DIFFERENT SUBSTRATES | MILLIKEN RESEARCH CORPORATION (US) | 2000-02-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100296049-A1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | VCL, MACF1, CFL1 | NPC1 3917/4885RAB9A 2881/4885LMNA 1029/4885 |
| US-12595368-B2 | UV/HEVL-filtering contact lenses | UACA, HSPA4L, RAD54L | NPC1 3998/4885RAB9A 4835/4885LMNA 2948/4885 |
| US-20240383865-A1 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | VCL, HBS1L, SAAL1 | NPC1 4212/4885RAB9A 4844/4885LMNA 2529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.